Most supplement ingredients have a simple origin story. A plant was traditionally used for a particular purpose. Someone tested it in a clinical trial. It worked well enough to make it onto a label. The history is brief, the mechanism is general, and the evidence is often modest.
Magtein has a different story entirely. It came out of one of the world's most respected research institutions, was developed to solve a specific and well-defined neurological problem, and has been validated in peer-reviewed human clinical trials with measurable effects on brain function. Understanding where it came from and why it was developed is the key to understanding why it is categorically different from every other magnesium supplement on the market.
The Problem Guosong Liu Set Out to Solve
Guosong Liu, PhD, a neuroscientist at the Massachusetts Institute of Technology, was studying the relationship between brain magnesium levels and cognitive function. His research had identified something that was not widely appreciated in either the scientific community or the supplement industry: the brain regulates its own magnesium compartment independently from the rest of the body.
This distinction is critical. Most people assume that when you supplement magnesium, you raise magnesium levels throughout your body including your brain. Liu's research showed this was not the case. Systemic magnesium levels in the blood and tissues can be normal or even elevated while brain magnesium remains low. The two compartments are independently regulated, and raising one does not reliably raise the other.
Liu also identified what low brain magnesium was doing to cognitive function. Magnesium plays a critical role in synaptic plasticity, the ability of neural connections to strengthen and adapt in response to learning and experience. It regulates NMDA receptors, which are the molecular gatekeepers of memory formation and learning. When brain magnesium is insufficient, these receptors do not function optimally, synaptic connections become less plastic, and cognitive performance declines in ways that manifest as poor memory, reduced focus, and impaired learning capacity.
The scientific question Liu's lab set out to answer was whether it was possible to develop a form of magnesium that could cross the blood-brain barrier efficiently enough to actually raise brain magnesium levels and produce measurable improvements in cognitive function.
The Blood-Brain Barrier Challenge
The blood-brain barrier is one of the most selective membranes in the human body. It is a tightly regulated interface between the bloodstream and brain tissue that allows essential nutrients through while blocking most other substances, including many medications and supplements that would otherwise reach the brain.
Most forms of magnesium, including magnesium oxide, citrate, glycinate, malate, and chloride, cross the blood-brain barrier in very limited quantities. The transport mechanisms available for magnesium in the blood-brain barrier are not efficiently activated by standard magnesium compounds. As a result, even consistent supplementation with high doses of these forms produces minimal increase in brain magnesium concentrations.
This is why most people who supplement magnesium for cognitive benefits report modest to no improvement on that dimension, even when they notice clear benefits for sleep quality and muscle function. Those benefits are real, but they are systemic benefits that do not require brain magnesium elevation. Cognitive improvements require getting magnesium into the brain, and standard forms largely cannot do that.
The Development of Magnesium L-Threonate
The solution Liu's team developed was to bind magnesium to L-threonate, a naturally occurring metabolite of vitamin C. This specific combination, tested alongside numerous other magnesium compounds, produced a result that no other form had achieved: significantly enhanced transport across the blood-brain barrier.
The reason for this enhanced transport is related to the way L-threonate interacts with transport mechanisms in the blood-brain barrier. The specific binding produces a compound that is more efficiently recognized and moved across the barrier than magnesium alone or magnesium bound to other compounds. The result is meaningfully higher brain magnesium concentrations from supplementation than any other form can achieve.
In animal studies conducted by Liu's team, magnesium L-threonate was the only form tested that produced a significant and consistent increase in cerebrospinal magnesium concentrations. The brain magnesium elevations produced by the compound were associated with measurable improvements in synaptic density in the hippocampus, the brain region most directly involved in memory and learning, and with significant improvements in cognitive performance across multiple memory tasks.
The compound was patented as Magtein and subsequently developed for human clinical use. Liu and his colleagues founded a company to bring the research to market, and the human clinical trials that followed confirmed what the animal research had shown: Magtein supplementation increases brain magnesium levels and produces measurable cognitive performance improvements in human subjects.
What the Human Clinical Research Confirmed
A randomized, double-blind, placebo-controlled human trial published in the Journal of Alzheimer's Disease examined the effects of Magtein supplementation on cognitive function in older adults with mild cognitive impairment. Participants supplementing Magtein showed significant improvements in overall cognitive ability, with particularly strong effects in executive function, working memory, and attention, compared to the placebo group. The researchers proposed brain magnesium elevation as the mechanism underlying these improvements.
Additional human research has demonstrated improvements in sleep quality, reduced anxiety, enhanced cognitive flexibility, and better performance on tasks requiring sustained attention and attention switching. These outcomes are consistent with what elevated brain magnesium would be expected to produce based on its known roles in NMDA receptor regulation and synaptic plasticity.
Why This Matters for 1UP Creatine + Magnesium L-Threonate
1UP Creatine + Magnesium L-Threonate delivers 1,000mg of Magtein per serving, providing 72mg of elemental magnesium in the form that Guosong Liu, PhD, and his MIT research team developed specifically to reach the brain.
Paired with 5g of Creatine Monohydrate, the most researched performance supplement in sports nutrition science, the formula covers physical and cognitive performance through two distinct and complementary mechanisms. Creatine supports ATP regeneration in both muscle and brain cells, improving physical performance and providing the energy substrate for sustained cognitive function. Magtein elevates brain magnesium to support synaptic function, memory, learning, and the focused mental clarity that extended cognitive work demands.
No other creatine product pairs creatine with an ingredient developed through MIT neuroscience research specifically to address brain magnesium. That is not a marketing distinction. It is a scientific one, rooted in over a decade of peer-reviewed research by one of the most credible research institutions in the world.
Shop Creatine + Magnesium L-Threonate
